Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio (2017 - 2018)

Teva Pharmaceutical Industries (TEVA) recorded quarterly FCF Payout Ratio of 0.01 in Q4 2018, down 283.12% on a QoQ basis from 0.01 in Q3 2018.

Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio (2017 - 2018) Analysis & Trends

Teva Pharmaceutical Industries has disclosed FCF Payout Ratio across 2 years of filings, most recently posting 0.01 for Q4 2018.

Quarterly FCF Payout Ratio changed N/A year-over-year to 0.01 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 0.01 (down 80.19% YoY) and the FY2019 annual result came in at 0.23, up 4085.65% from the prior year.
FCF Payout Ratio declined to 0.01 in Q4 2018, from 0.01 in the prior quarter.
Over five years, FCF Payout Ratio peaked at 1.43 in Q2 2017 and troughed at 5.24 in Q1 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	-
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	0.77
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	-
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	-
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	-
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	-
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	-
10	Liquidia	5.63 Bn	5.40 Bn	121.79 Mn	-

Download Data